Filing Details

Accession Number:
0001213900-24-016026
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-22 13:38:46
Reporting Period:
2024-02-21
Accepted Time:
2024-02-22 13:38:46
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1728328 Inmed Pharmaceuticals Inc. INM Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1818252 Andrew Hull C/O Inmed Pharmaceuticals Inc.
310-815 West Hastings St.
Vancouver A1 V6C1B4
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-21 37,500 $0.39 38,258 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct